跳至主要内容
临床试验/NCT04568655
NCT04568655已完成不适用

The Noninvasive Ventilation to COVID-19 Patients With Respiratory Failure

The First Affiliated Hospital of Guangzhou Medical University1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23
试验地点
1
主要终点
the intubtion rate

研究概览

简要总结

Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.

详细描述

Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.We wish to raise the success rate to COVID-19 patients with respiratory failure.More critically ill COVID-19 patients could avoid the intubtion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Shortness of breath, RR>30 times per minute;
  • At room air, SpO2 lower than 93%;
  • The partial pressure of Arterial blood oxygen (PaO2)/the fraction of inspired oxygen (FiO2) ≤ 300mmHg;
  • CT(computed tomography) chest imaging shows that lung damage develops significantly within 24 to 48 hours.

排除标准

  • Severe cardiovascular disease,
  • respiratory arrest,
  • cardiovascular instability (hypotension, arrhythmias, myocardial infarction),
  • change in mental status or patients who were uncooperative, high risk of aspiration, viscous or copious
  • secretions,
  • recent facial or gastroesophageal surgery,
  • craniofacial trauma, 8)fixed nasopharyngeal abnormalities,
  • 9)burns, 10) extreme obesity.

结局指标

主要结局

the intubtion rate

时间窗: 4 month

the intubtion rate of the COVID-19 patients

success rate

时间窗: 4 month

the sucess rate of the noninvasive ventilation

次要结局

  • blood lymphocyte(4month)
  • Procalcitonin(4 month)
  • B-type natriuretic peptide(4 month)
  • Oxygen Saturation(4 month)

研究者

发起方
The First Affiliated Hospital of Guangzhou Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhang Jianheng

The First Affiliated Hospital of Guangzhou Medical University

The First Affiliated Hospital of Guangzhou Medical University

研究点 (1)

Loading locations...

相似试验